[1]
|
Serban, D.E. (2015) Microbiota in Inflammatory Bowel Disease Pathogenesis and Therapy: Is It All About Diet? Nutri-tion in Clinical Practice, 30, 760-779. https://doi.org/10.1177/0884533615606898
|
[2]
|
Ramos, G.P. and Papadakis, K.A. (2019) Mechanisms of Disease: Inflammatory Bowel Diseases. Mayo Clinic Proceedings, 94, 155-165. https://doi.org/10.1016/j.mayocp.2018.09.013
|
[3]
|
Yen, H.H., Weng, M.T., Tung, C.C., Wang, Y.T., Chang, Y.T., Chang, C.H., Shieh, M.J., Wong, J.M. and Wei, S.C. (2019) Epidemiological Trend in Inflammatory Bowel Disease in Taiwan from 2001 to 2015: A Nationwide Population-Based Study. Intestinal Research, 17, 54-62. https://doi.org/10.5217/ir.2018.00096
|
[4]
|
Kaplan, G.G. (2015) The Global Burden of IBD: From 2015 to 2025. Nature Reviews Gastroenterology & Hepatology, 12, 720-727. https://doi.org/10.1038/nrgastro.2015.150
|
[5]
|
Kostic, A.D., Xavier, R.J. and Gevers, D. (2014) The Microbiome in Inflammatory Bowel Disease: Current Status and the Future Ahead. The Journal of Gastroenterology, 146, 1489-1499. https://doi.org/10.1053/j.gastro.2014.02.009
|
[6]
|
Aldars-García, L., Marin, A.C., Chaparro, M. and Gisbert, J.P. (2021) The Interplay between Immune System and Microbiota in Inflammatory Bowel Disease: A Narrative Review. In-ternational Journal of Molecular Sciences, 22, 3076.
https://doi.org/10.3390/ijms22063076
|
[7]
|
Sheil, B., Shanahan, F. and O’Mahony, L. (2007) Probiotic Effects on Inflammatory Bowel Disease. The Journal of Nutrition, 137, 819S-824S. https://doi.org/10.1093/jn/137.3.819S
|
[8]
|
Dunne, C., Murphy, L., Flynn, S., O’Mahony, L., O’Halloran, S., Feeney, M., Morrissey, D., Thornton, G., Fitzgerald, G., Daly, C., Kiely, B., Quigley, E.M., O’Sullivan, G.C., Shanahan, F. and Collins, J.K. (1999) Probiotics: From Myth to Reality. Demonstration of Functionality in Animal Models of Dis-ease and in Human Clinical Trials. Antonie Van Leeuwenhoek, 76, 279-292. https://doi.org/10.1023/A:1002065931997
|
[9]
|
Borchers, A.T., Selmi, C., Meyers, FJ, Keen, C.L. and Gershwin, M.E. (2009) Probiotics and Immunity. Journal of Gastroenterology, 44, 26-46. https://doi.org/10.1007/s00535-008-2296-0
|
[10]
|
Gao, J., Li, Y., Wan, Y., Hu, T., Liu, L., Yang, S., Gong, Z., Zeng, Q., Wei, Y., Yang, W., Zeng, Z., He, X., Huang, S.H. and Cao, H. (2019) A Novel Postbiotic from Lactobacillus rhamnosus GG with a Beneficial Effect on Intestinal Barrier Function. Frontier in Microbiology, 10, Article No. 477. https://doi.org/10.3389/fmicb.2019.00477
|
[11]
|
Qiao, Y., Qiu, Z., Tian, F., Yu, L., Zhao, J., Zhang, H., Zhai, Q. and Chen, W. (2021) Pediococcus acidilactici Strains Improve Constipation Symptoms and Regulate Intestinal Flora in Mice. Frontiers in Cellular and Infection Microbiology, 11, Article ID: 655258. https://doi.org/10.3389/fcimb.2021.655258
|
[12]
|
Umu, Ö.C., Bäuerl, C., Oostindjer, M., Pope, P.B., Hernández, P.E., Pérez-Martínez, G. and Diep, D.B. (2016) Thepotential of Class II Bacteriocins to Modify Gut Microbiota to Im-prove Host Health. PLoS ONE, 11, e0164036.
https://doi.org/10.1371/journal.pone.0164036
|
[13]
|
Zommiti, M., Bouffartigues, E., Maillot, O., Barreau, M., Szunerits, S., Sebei, K., Feuilloley, M., Connil, N. and Ferchichi, M. (2018) In Vitro Assessment of the Probiotic Prop-erties and Bacteriocinogenic Potential of Pediococcus pentosaceus MZF16 Isolated from Artisanal Tunisianmeat “Dried Ossban”. Frontiers in Microbiology, 9, Article No. 2607.
https://doi.org/10.3389/fmicb.2018.02607
|
[14]
|
Perše, M. and Cerar, A. (2012) Dextran Sodium Sulphate Colitis Mouse Model: Traps and Tricks. Journal of Biomedicine and Biotechnology, 2012, Article ID: 718617. https://doi.org/10.1155/2012/718617
|
[15]
|
Eichele, D.D. and Kharbanda, K.K. (2017) Dextran Sodium Sulfate Coli-tis Murine Model: An Indispensable Tool for Advancing Our Understanding of Inflammatory Bowel Diseases Patho-genesis. World Journal of Gastroenterology, 23, 6016-6029. https://doi.org/10.3748/wjg.v23.i33.6016
|
[16]
|
Wirtz, S., Neufert, C., Weigmann, B. and Neurath, M.F. (2007) Chemically Induced Mouse Models of Intestinal Inflammation. Nature Protocols, 2, 541-546. https://doi.org/10.1038/nprot.2007.41
|
[17]
|
Okayasu, I., Hatakeyama, S., Yamada, M., Ohkusa, T., Inagaki, Y. and Nakaya, R. (1990) A Novel Method in the Induction of Reliable Experimental Acute and Chronic Ulcerative Colitis in Mice. Gastroenterology, 98, 694-702.
https://doi.org/10.1016/0016-5085(90)90290-H
|
[18]
|
Mizoguchi, E., Low, D., Ezaki, Y. and Okada, T. (2020) Re-cent Updates on the Basic Mechanisms and Pathogenesis of Inflammatory Bowel Diseases in Experimental Animal Models. Intestinal Research, 18, 151-167.
https://doi.org/10.5217/ir.2019.09154
|
[19]
|
Chassaing, B., Aitken, J. D., Malleshappa, M. and Vijay-Kumar, M. (2014) Dextran Sulfate Sodium (DSS)-Induced Colitis in Mice. Current Protocols in Immunology, 104, 15.25.1-15.25.14.
https://doi.org/10.1002/0471142735.im1525s104
|
[20]
|
Zhang, Y., Zhao, X., Zhu, Y., Ma, J., Ma, H. and Zhang, H. (2018) Probiotic Mixture Protects Dextran Sulfate Sodium-Induced Colitis by Altering Tight Junction Protein Expres-sions and Increasing Tregs. Mediators of Inflammation, 2018, Article ID: 9416391. https://doi.org/10.1155/2018/9416391
|
[21]
|
Yen, H.H., Weng, M.T., Tung, C.C., Wang, Y.T., Chang, Y.T., Chang, C.H., Shieh, M.J., Wong, J.M. and Wei, S.C. (2019) Epidemiological Trend in Inflammatory Bowel Disease in Taiwan from 2001 to 2015: A Nationwide Population-Based Study. Intestinal Research, 17, 54-62. https://doi.org/10.5217/ir.2018.00096
|
[22]
|
Ng, S.C., Shi, H.Y., Hamidi, N., Underwood, F.E., Tang, W., Benchimol, E.I., Panaccione, R., Ghosh, S., Wu, J.C.Y., Chan, F.K.L., Sung, J.J.Y. and Kaplan, G.G. (2017) Worldwide Incidence and Prevalence of Inflammatory Bowel Disease in the 21st Century: A Systematic Review of Population-Based Studies. The Lancet, 390, 2769-2778.
https://doi.org/10.1016/S0140-6736(17)32448-0
|
[23]
|
Ng, W.K., Wong, S.H. and Ng, S.C. (2016) Changing Epi-demiological Trends of Inflammatory Bowel Disease in Asia. Intestinal Research, 14, 111-119. https://doi.org/10.5217/ir.2016.14.2.111
|
[24]
|
Wong, M.C., Ding, H., Wang, J., Chan, P.S. and Huang, J. (2019) Prevalence and Risk Factors of Colorectal Cancer in Asia. Intestinal Research, 17, 317-329. https://doi.org/10.5217/ir.2019.00021
|
[25]
|
Lewis, J.D. and Abreu, M.T. (2017) Diet as a Trigger or Therapy for Inflammatory Bowel Diseases. The Journal of Gastroenterology, 152, 398-414. https://doi.org/10.1053/j.gastro.2016.10.019
|
[26]
|
Lichtenstein, G.R., Loftus, E.V., Isaacs, K.L., Regueiro, M.D., Gerson, L.B. and Sands, B.E. (2018) ACG Clinical Guideline: Management of Crohn’s Disease in Adults. The American Journal of Gastroenterology, 113, 481-517.
https://doi.org/10.1038/ajg.2018.27
|
[27]
|
Shafiee, N.H., Manaf, Z.A., Mokhtar, N.M. and Raja Ali, R.A. (2021) Anti-Inflammatory Diet and Inflammatory Bowel Disease: What Clinicians and Patients Should Know? Intestinal Re-search, 19, 171-185.
https://doi.org/10.5217/ir.2020.00035
|
[28]
|
Kruis, W., Fric, P., Pokrotnieks, J., Lukás, M., Fixa, B., Kascák, M., Kamm, M.A., Weismueller, J., Beglinger, C., Stolte, M., Wolff, C. and Schulze, J. (2004) Maintaining Remission of Ul-cerative Colitis with the Probiotic Escherichia coli Nissle 1917 Is as Effective as with Standard Mesalazine. Gut, 53, 1617-1623.
https://doi.org/10.1136/gut.2003.037747
|
[29]
|
Fujiya, M., Ueno, N. and Kohgo, Y. (2014) Probiotic Treatments for Induction and Maintenance of Remission in Inflammatory Bowel Diseases: A Meta-Analysis of Randomized Controlled Trials. Clinical Journal of Gastroenterology, 7, 1-13. https://doi.org/10.1007/s12328-013-0440-8
|
[30]
|
Mitselou, A., Grammeniatis, V., Varouktsi, A., Papadatos, S.S., Katsanos, K. and Galani, V. (2020) Proinflammatory Cytokines in Ir-ritable Bowel Syndrome: A Comparison with Inflammatory Bowel Disease. Intestinal Research, 18, 115-120. https://doi.org/10.5217/ir.2019.00125
|
[31]
|
Wang, L., Walia, B., Evans, J., Gewirtz, A.T., Merlin, D. and Sitaraman, S.V. (2003) IL-6 Induces NF-kappa B Activation in the Intestinal Epithelia. The Journal of Immunology, 171, 3194-3201.
https://doi.org/10.4049/jimmunol.171.6.3194
|